乐心医疗(300562.SZ)：心康医疗拟以增资扩股方式进行股权融资

Core Viewpoint - 乐心医疗 is undergoing a capital increase and share transfer involving its subsidiary, Shenzhen Xinkang Medical Technology Co., Ltd, to enhance operational efficiency and align with its long-term strategic planning [1][2] Group 1: Capital Increase and Share Transfer - Shenzhen Xinkang Medical plans to raise capital through a share expansion, introducing new shareholder Shenzhen Huize Tiancheng Equity Investment Fund Partnership, which will invest RMB 12 million, with RMB 2 million as registered capital and RMB 10 million as capital reserve [1] - After the capital increase, Huize Tiancheng will hold 6.25% of Xinkang Medical, while 中山乐恒's share will decrease from 30.00% to 28.125%, and 潮牛医疗's share will decrease from 20.00% to 18.75% [1] - 中山乐恒 intends to transfer 18.75% of its shares in Xinkang Medical to individuals Liu Hao and Liao Yunpeng, with each acquiring 9.375% for RMB 3 million [1] - 潮牛医疗 will also transfer its 18.75% stake in Xinkang Medical to Liu Hao and Liao Yunpeng under the same terms [1] Group 2: Company Rights and Decisions - The company has the priority subscription rights for the capital increase and the priority purchase rights for the share transfer, but has decided to waive these rights based on the current operational situation and future planning [2]